Skip to content

Effects of fig tea on atopic dermatitis. Placebo-controlled, double-blind, randomized trial

Effects of fig tea on atopic dermatitis. Placebo-controlled, double-blind, randomized trial - Atopic dermatitis inhibitory effects of fig tea.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039753
Enrollment
30
Registered
2021-07-07
Start date
2020-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Drink 500 mL of fig tea daily for 8 weeks. Drink 500 mL of water daily for 8 weeks.

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Person who have mild symptoms of atopic dermatitis.

Exclusion criteria

Exclusion criteria: 1) Person who has a history of diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disease, other severe disease. 2) Person who has food or medicine allergy. 3) Person who plan to use medicines due to atopic dermatitis. 4) Anemia patients. 5) Overdose of alcohol. 6) Those who are planning to become pregnant or breast-feeding during the examination period. 7) Participants in other clinical trials or those planning to participate. 8) Person who the attending physician determines inappropriate.

Design outcomes

Primary

MeasureTime frame
Differences in the symptoms of atopic dermatitis between the test food group and the control food group were determined by the EASI (Eczema Area and Severity Index), blood biochemical tests, POEM (Patient-Oriented Eczema Measure) at 4, 8, and 12 weeks after ingestion.

Secondary

MeasureTime frame
VAS Quetionnaire (Skin condition, Itch, Medical Condition)

Countries

Japan

Contacts

Public ContactTatsuya Abe

Toyo institute of food technology Research department

tatsuya_abe@shokuken.or.jp072-740-3300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026